<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04313621</url>
  </required_header>
  <id_info>
    <org_study_id>123456789</org_study_id>
    <nct_id>NCT04313621</nct_id>
  </id_info>
  <brief_title>Management of Lower Limb Apophysitis: A Cross-sectional Study on Long-term Impact on Health Status</brief_title>
  <official_title>Management of Lower Limb Apophysitis: A Cross-sectional Study on Long-term Impact on Health Status</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hvidovre University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lower limb apophysitis cause long-term pain, decrease in function, and can reduce or
      completely hinder participation in sports and physical activity, yet there is little
      knowledge on the long-term consequences for health. Our objective with this investigation is
      to capture self-reported health-status for all adults having been diagnosed with lower limb
      apophysitis in the period of 1977 to 2020 and compared these data with normative values for
      the background population. We are therefore conducting a national cross-sectional study based
      on data from the Danish National Patient Registry. In this protocol we describe, as detailed
      as possible, the planned methods.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Physical and mental health</measure>
    <time_frame>Baseline</time_frame>
    <description>SF-12 (Short-form 12 item) health survey</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sleep: problems and duration</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mental health</measure>
    <time_frame>Baseline</time_frame>
    <description>PSEQ-2 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological Question</measure>
    <time_frame>Baseline</time_frame>
    <description>Yes/no, ad modum Vægter, et al. 2018</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported level of satisfaction with participation in physical activity and sports</measure>
    <time_frame>Baseline</time_frame>
    <description>Tegner activity scale (0-10, 10 being no physical activity) and individual specific specific questions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee pain</measure>
    <time_frame>Baseline</time_frame>
    <description>Evaluated on at 0-100 numerical pain rating scale pertaining (0 being no pain) to the knee or other body parts, and worst pain last week or the last month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported health</measure>
    <time_frame>Baseline</time_frame>
    <description>EuroQoL 0-100 VAS scale (100 being the best health state imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>KOOS subscales</measure>
    <time_frame>Baseline</time_frame>
    <description>Knee injury and Osteoarthritis Outcome Score (KOOS) and its 5 subscale each scoring 0-100, with 100 being the no problems.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Comorbidities from the Charlson Comorbidity Score</measure>
    <time_frame>Baseline</time_frame>
    <description>Rated as having either 0, 1, 2, or ≥3 comorbidities.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Lower Limb Apophysitis (Severs, Osgood Schlatter, Sinding-Larsen Johansson)</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Sample size will be of convenience with no pre-determined cut-off for smallest or largest
        sample of interest, rather, the final sample of respondents will be based on however many
        have been designated the diagnostic codes and responds to the survey.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients aged 18-55 having received diagnostics codes pertaining to lower limb
             apophysitis (Severs, Sinding-Larsen Johansson, Osgood Schlatter) in the years
             1977-2020 in Denmark will be eligible to participate.

        Exclusion Criteria:

          -  Diseased participants will be censored
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kasper Krommes</name>
      <address>
        <city>Hvidovre</city>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <contact>
      <last_name>Kasper Krommes, MSc</last_name>
      <phone>23 65 35 72</phone>
      <email>kasper.krommes@regionh.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 17, 2020</study_first_submitted>
  <study_first_submitted_qc>March 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2020</study_first_posted>
  <last_update_submitted>March 18, 2020</last_update_submitted>
  <last_update_submitted_qc>March 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hvidovre University Hospital</investigator_affiliation>
    <investigator_full_name>Kasper Krommes</investigator_full_name>
    <investigator_title>Clinical Research Coordinator, PhD-fellow, Physiotherapist, MSc</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The full dataset, excluding all personal identifiers, will be posted alongside the pre-print when the results have been disseminated.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>After primary publication and for the foreseeable futures thereafter.</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

